Hypoport AG

EANS-News: Hypoport-subsidiary Dr. Klein presents good figures and new solutions in talks during the EXPO REAL 2009

@@start.t1@@--------------------------------------------------------------------------------   Corporate news transmitted by euro adhoc. The issuer/originator is solely   responsible for the content of this announcement. --------------------------------------------------------------------------------@@end@@

Financial Figures/Balance Sheet/Company Information

Berlin, (euro adhoc) - 5 October 2009: Dr. Klein is  clearly  setting itself apart  from  its competitors in the marketplace with a growth rate in excess of  30  percent  for all financing transaction settlements over the last 12  months.  The  volume  in the most important sub-segment - long-term new business - even increased  by   75 percent. The good figures are the result of the in-depth   understanding  of  the sector that the financial  services  provider has  been  building  since  1954, combined with its ability to   flexibly  adapt  to  new  market  conditions.  The developments of the market leader will be addressed  in  more  detail  during  a theme discussion at the EXPO REAL.

The total volume of financing transactions arranged by Dr. Klein increased by 30 percent over the last twelve months from EUR 1,332 million (Q4/2007-Q3/2008) to their current level of EUR 1,750 million (Q4/2008-Q3/2009). The 75 percent increase from EUR 800 million to EUR 1,408 million in long-term new business - the most important sub-segment - is an even better reflection of this positive development.

Good reasons for good figures Dr. Klein has clearly distanced itself from  the  general  developments  in  the marketplace - since the financial crisis started gaining  in  intensity  a  year ago. Hans Peter Trampe, responsible member of the management  board,   attributes these good figures to  a  number  of  reasons.  Potential borrowers  are  still finding it difficult to identify who is nowadays willing to lend  money.  Thanks to its extensive network and the relationships of trust that the  market  leader has built up over the years to potential lenders,  Dr.  Klein  can  provide  its clients with the necessary information. Creating this  market   transparency  is, however, just one of the important success factors. Impartial advisory  services that help clients, among other things,   to  optimise  their  interest  rate  and collateral structures also contributed  to  the  positive  result.  In  Trampe's opinion, these services, in particular, are  an  absolutely  crucial  aspect  of addressing the demand for financing  products,  given  the  marked   increase  in margins at high loan to value ratios.

New solutions for new market conditions The news from the financial products marketplace is, however, not all  negative: "Many insurance companies and pension funds are discovering the benefits of  the real estate sector as a comparatively low-risk asset class. And some   banks  who scorned the tight margins offered by such business in the past are now  learning to appreciate the solid strength of the sector", is  how  Trampe  describes  the current market situation. Dr. Klein offers innovative  solutions  to  these  new market players: According to Trampe: "Bearer bonds issued by the borrowers   even enable us to service lenders who are not actually allowed to   engage  in  credit business themselves".

Success also extends to large-scale financing transactions Over the   past  12  months,  Dr.  Klein  has  been  particularly  successful   in financing large deals. "The market is particularly narrow at this end. The  "why not take a bit more?" attitude of former times has now been replaced  with  "the more you want the  more  it  costs".  Only very  few  lenders  are  capable  of financing 50  million  Euros  or even  more  without  difficulties.  Dr.  Klein therefore compiles syndicates to arrange  the  financing  of  large  deals,  but without binding the individual lenders to each other as is often the  case   with classic bank syndicates. The dependency on a syndicate or the   lead  manager  of the same is eliminated, thus giving the borrower   much  more  independence  than would be the case with a classic syndicate management structure.

Discussion at the EXPO REAL 2009 Trampe will provide more detailed explanations with special focus on the new solutions at the EXPO REAL. He will be addressing new financing approaches and opportunities in the theme discussion with journalist and presenter Miriam Beul on Monday, 5 October 2009. The discussion entitled "How are major real estate deals financed nowadays? New approaches, new opportunities!" will take place at the BSI booth, Hall B2, Booth 220 on Monday, starting at 3:30 p.m.

+ + +  Die Dr. Klein & Co. AG, a wholly owned subsidiary of Hypoport AG, which is listed in the Prime Standard, can be found in Hall B2 at Booth 220 at the EXPO REAL. + + +

About Dr. Klein The Corporate Clients business unit at Dr. Klein & Co. AG was set up in 1954  to develop provider-neutral financing and insurance  solutions  for  companies  and municipalities. The German residential industry constitutes the  largest  client group; Dr. Klein leads the market for arranging loans in this sector. The  range of offered services encompasses the  organisation  of  low-cost   loans  and  the provision of  advice  on  optimising  financing   structures,  right  up  to  the development of customised insurance solutions. In providing these services,  Dr. Klein makes the best use of its network consisting of a large number  of  banks, insurance companies and pension funds. Our clients benefit  from  the   synergies within Hypoport Group,  for  example  when  using  the   EUROPACE-WoWi  portfolio management system or  when  procuring   bank-neutral  financing  on  the  capital market. In doing so, assets valued far in excess of one billion  Euros  are  re- financed and insured each  year.  Regardless  of  whether  private  clients  are looking  for  current  accounts,  call  money,  insurance  policies, financial investments, mortgage financing or private loans, Dr.   Klein  can  provide  them with just the right product to meet their individual requirements.

@@start.t2@@Ende der Mitteilung                                                 euro adhoc
--------------------------------------------------------------------------------@@end@@

ots Originaltext: Hypoport AG
Im Internet recherchierbar: http://www.presseportal.ch

Further inquiry note:
Michaela Reimann
Group Communications Manager
Telefon: +49(0)30 42086-1936
E-Mail: michaela.reimann@hypoport.de

Branche: Financial & Business Services
ISIN:      DE0005493365
WKN:        549336
Börsen:  Frankfurt / regulated dealing/prime standard



Weitere Meldungen: Hypoport AG

Das könnte Sie auch interessieren: